Keywords: مهارکننده PDE5; erectile dysfunction; orodispersible tablet; PDE5 inhibitor; sildenafil citrate;
مقالات ISI مهارکننده PDE5 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهارکننده PDE5; basal cell carcinoma; melanoma; meta-analysis; PDE5 inhibitor; squamous cell carcinoma; BCC; basal cell carcinoma; cGMP; cyclic guanosine-3â²,5â²-monophosphate; CI; confidence interval; NOS; Newcastle-Ottawa quality-assessment scale; OR; odds ratio; PDE
Keywords: مهارکننده PDE5; erectile dysfunction; PDE5 inhibitor; sildenafil; tadalafil; vardenafil
Keywords: مهارکننده PDE5; Pharmacokinetics; Vardenafil; Inhalation; Comparative; PDE5 Inhibitor
Keywords: مهارکننده PDE5; Erectile Dysfunction; Hypogonadism; Testosterone; PDE5 Inhibitor;
3,7-Bis(2-hydroxyethyl)icaritin, a potent inhibitor of phosphodiesterase-5, prevents monocrotaline-induced pulmonary arterial hypertension via NO/cGMP activation in rats
Keywords: مهارکننده PDE5; 3,7-Bis(2-hydroxyethyl)icaritin; Pulmonary arterial hypertension; PDE5 inhibitor; NO; cGMP;
PDE 5 inhibitor improves insulin sensitivity by enhancing mitochondrial function in adipocytes
Keywords: مهارکننده PDE5; Adipocyte; Insulin sensitivity; Mitochondrial function; PDE5 inhibitor;
Phosphodiesterase 5 inhibition as a therapeutic target for ischemic stroke: A systematic review of preclinical studies
Keywords: مهارکننده PDE5; Akt; protein kinase B; Bax; bcl-2-like protein 4; BCCAO; bilateral common carotid artery occlusion; Bcl-xL; B-cell lymphoma-extra large; bcl-2; B-cell lymphoma 2; MAPK; mitogen-activated protein kinase; MCAO; middle cerebral artery occlusion; PDE5i; phosp
Effects of Tadalafil Once-Daily or On-Demand vs Placebo on Return to Baseline Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy – Results from a Randomized Controlled Trial (REACTT)
Keywords: مهارکننده PDE5; Prostate Cancer; Radical Prostatectomy; Erectile Dysfunction; PDE5 Inhibitor; Tadalafil; REACTT; IIEF-EF; Back to Baseline
Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 Dysregulation
Keywords: مهارکننده PDE5; Sickle Cell Disease; Endothelial Nitric Oxide Synthase; Reactive Oxygen Species; Phosphodiesterase 5; Priapism; PDE5 Inhibitor
Effects of Tadalafil on Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia and on Erectile Dysfunction in Sexually Active Men with Both Conditions: Analyses of Pooled Data from Four Randomized, Placebo‐Controlled Tadalafil Clinical Stu
Keywords: مهارکننده PDE5; PDE5 Inhibitor; Tadalafil; Benign Prostatic Hyperplasia; Erectile Dysfunction; Lower Urinary Tract Symptoms; LUTS/BPH
Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease
Keywords: مهارکننده PDE5; PDE5 inhibitor; Alzheimer's disease; Quinoline derivative; cGMP; Memory; Long-term potentiation
Adherence to Initial PDE5 Inhibitor Treatment: Randomized OpenLabel Study Comparing Tadalafil Once a Day, Tadalafil on Demand, and Sildenafil on Demand in Patients with Erectile Dysfunction
Keywords: مهارکننده PDE5; PDE5 Inhibitor; Treatment Adherence; Erectile Dysfunction; Tadalafil; Sildenafil; Psychosocial Outcomes
Toward Personalized Sexual Medicine (Part 2): Testosterone Combined with a PDE5 Inhibitor Increases Sexual Satisfaction in Women with HSDD and FSAD, and a Low Sensitive System for Sexual Cues
Keywords: مهارکننده PDE5; Testosterone; PDE5 Inhibitor; HSDD; Sensitivity for Sexual Cues; Hypoactive Sexual Desire Disorder;
Increasing the Dose of Vardenafil on a Daily Basis Does Not Improve Erectile Function after Unilateral Nerve‐Sparing Radical Prostatectomy
Keywords: مهارکننده PDE5; Erectile Dysfunction; Rehabilitation; Nerve‐Sparing Radical Prostatectomy; Prostate Cancer; PDE5 Inhibitor; Vardenafil; Erectile Function Preservation
Selectivity of Avanafil, a PDE5 Inhibitor for the Treatment of Erectile Dysfunction: Implications for Clinical Safety and Improved Tolerability
Keywords: مهارکننده PDE5; Avanafil; PDE5 Inhibitor; Erectile Dysfunction; Selectivity; Inhibition; Adverse Events
The concept of erectile function preservation (penile rehabilitation) in the patient after brachytherapy for prostate cancer
Keywords: مهارکننده PDE5; Prostate cancer; Radiation; Brachytherapy; Erectile function; Rehabilitation; PDE5 inhibitor;
Assessment of the Effect of Mirodenafil on the Hemodynamics of Healthy Male Korean Volunteers Administered Tamsulosin: A Randomized, Double-Blind, Placebo-Controlled, 2-Period Crossover Study
Keywords: مهارکننده PDE5; α1-adrenergic receptor antagonist; hemodynamics; mirodenafil; PDE5 inhibitor; tamsulosin
Metal ion stimulators of PDE5 cause similar conformational changes in the enzyme as does cGMP or sildenafil
Keywords: مهارکننده PDE5; PDE; cyclic nucleotide phosphodiesterase; PAGE; polyacrylamide gel electrophoresis; SDS; sodium dodecyl sulfate; KPEM; 10 mM potassium phosphate (pH 6.8) containing 1 mM EDTA and 25 mM β-mercaptoethanol; GAF; cGMP-binding PDE, Anabaenaadenylyl cyclase
The Controversial Role of Phosphodiesterase Type 5 Inhibitors in the Treatment of Premature Ejaculation
Keywords: مهارکننده PDE5; Ejaculation; Premature Ejaculation; SSRI; PDE5 Inhibitor; Sildenafil; Vardenfil; Tadalafil;
Rehabilitative therapy for erectile function after nerve-sparing radical prostatectomy
Keywords: مهارکننده PDE5; Erectile dysfunction; Rehabilitation; Nerve-sparing radical prostatectomy; Prostate cancer; PDE5 inhibitor
Sildenafil promotes adipogenesis through a PKG pathway
Keywords: مهارکننده PDE5; Adipogenesis; PDE5 inhibitor; PKG; Adipocytes
Combination of Alfuzosin and Tadalafil Exerts an Additive Relaxant Effect on Human Detrusor and Prostatic Tissues In Vitro
Keywords: مهارکننده PDE5; PDE5 inhibitor; α1-adrenoceptor antagonist; Lower urinary tract symptoms; Bladder; Prostate; Smooth muscle
Mise au point thérapeutique : la dysfonction érectile chez le diabétique
Keywords: مهارکننده PDE5; Dysfonction érectile; traitement; diabète; bilan; inhibiteur de la PDE5; Erectile dysfunction; treatment; diabetes mellitus; screening; PDE5 inhibitor;
Efficacy and Safety of Mirodenafil in Men Taking Antihypertensive Medications
Keywords: مهارکننده PDE5; Erectile Dysfunction; PDE5 inhibitor; Antihypertensives; Mirodenafil;
Erectile Function Rehabilitation in the Radical Prostatectomy Patient
Keywords: مهارکننده PDE5; Prostate Cancer; Prostatectomy; Radiation; Rehabilitation; PDE5 Inhibitor; Intracavernosal Injections; Smooth Muscle; Collagen; Oxygenation;
Pourquoi et comment explorer la fonction érectile chez un patient à risque cardiovasculaire ?
Keywords: مهارکننده PDE5; Dysfonction érectile; Maladie cardiovasculaire; Symptôme sentinelle; Inhibiteur de la phosphodiestérase 5Erectile dysfunction; Cardiovascular disease; Sentinel symptom; PDE5 inhibitor
Allosteric-site and catalytic-site ligand effects on PDE5 functions are associated with distinct changes in physical form of the enzyme
Keywords: مهارکننده PDE5; PDE; cyclic nucleotide phosphodiesterase; IBMX; 3-isobutyl-1-methylxanthine; C domain; catalytic domain; R domain; regulatory domain; PAGE; polyacrylamide gel electrophoresis; KP; 10Â mM potassium phosphate (pH 6.8); GAF; cGMP-binding PDE, Anabaenaadenyly
Safety, Efficacy, and Pharmacokinetic Overview of Low-Dose Daily Administration of Tadalafil
Keywords: مهارکننده PDE5; Pharmacokinetic/Parmacodynamic; Simulation; Tadalafil; As Needed; Once-daily Use; PDE5 Inhibitor;
Combination of Doxazosin and Sildenafil Exerts an Additive Relaxing Effect Compared with Each Compound Alone on Human Cavernosal and Prostatic Tissue
Keywords: مهارکننده PDE5; PDE5 Inhibitor; Alpha1-Adrenoceptor Antagonist; Lower Urinary Tract; Symptoms; Erectile Dysfunction; Benign Prostatic Hyperplasia;
Continuing Medical Education: 2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 2: Updates on Optimal Utilization for Sexual Concerns and Rare Toxicities in This Class (CME)
Keywords: مهارکننده PDE5; PDE5 Inhibitor; Impotence; Premature Ejaculation; Erectile Dysfunction; Sexual Dysfunction; Toxicity;
Highly potent and selective chiral inhibitors of PDE5: An illustration of Pfeiffer’s rule
Keywords: مهارکننده PDE5; Pfeiffer’s rule; Eudismic analysis; Eudismic; PDE5; PDE5 inhibitor; Sildenafil; UK-343,664; UK-371,800; Non-linear pharmacokinetics
An Evaluation of Semen Characteristics in Men 45 Years of Age or Older after Daily Dosing with Tadalafil 20 mg: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, 9-Month Study
Keywords: مهارکننده PDE5; Tadalafil; PDE5 inhibitor; Spermatogenesis; Testosterone; Follicle-stimulating hormone; Luteinizing hormone; Semen parameters
Comparative Efficacy Assessment of Tamsulosin vs. Tamsulosin Plus Tadalafil in the Treatment of LUTS/BPH. Pilot Study
Keywords: مهارکننده PDE5; Benign Prostatic Hyperplasia; Erectile Dysfunction; LUTS; PDE5 Inhibitor;
PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model
Keywords: مهارکننده PDE5; BBB, blood–brain barrier; BTB, blood–brain tumor barrier; BK, bradykinin; B2R, bradykinin-2 receptor; KCa, calcium-dependent potassium; RMP-7, lobradimil; IBTX, iberiotoxin; SIL, sildenafil; VAR, vardenafilBrain tumor; PDE5 inhibitor; Drug transport; Drug
Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction
Keywords: مهارکننده PDE5; α1-Blocker; PDE5 inhibitor; Lower urinary tract symptoms; Sexual dysfunction; Alfuzosin; Sildenafil
Efficacy and Safety of Tadalafil in Men with Erectile Dysfunction with a High Prevalence of Comorbid Conditions: Results from MOMENTUS: Multiple Observations in Men with Erectile Dysfunction in National Tadalafil Study in the US
Keywords: مهارکننده PDE5; PDE5 Inhibitor; Comorbid Conditions; Erectile Dysfunction;
The Role of Erection Hardness in Determining Erectile Dysfunction (ED) Treatment Outcome
Keywords: مهارکننده PDE5; Erectile dysfunction; Erection hardness; Intimacy; PDE5 inhibitor; Self-esteem; Sexual satisfaction
Effective Erectile Dysfunction (ED) Treatment Enables Men to Enjoy Better Sex: The Importance of Erection Hardness, Psychological Well-Being, and Partner Satisfaction
Keywords: مهارکننده PDE5; Erectile dysfunction; Erection hardness; Partner satisfaction; PDE5 inhibitor; Psychological well-being; Sexual health
Sildenafil Non-Responders: Haemodynamic and Morphometric Studies
Keywords: مهارکننده PDE5; Erectile dysfunction; PDE5 inhibitor; Sildenafil non-responder; Impotence;
Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED
Keywords: مهارکننده PDE5; PDE5 inhibitor; Erectile dysfunction; Male ED; Purine
Synthesis and phosphodiesterase 5 inhibitory activity of novel pyrido[1,2-e]purin-4(3H)-one derivatives
Keywords: مهارکننده PDE5; Pyrido[1,2-e]purin-4(3H)-one; PDE5 Inhibitor; Sildenafil; Erectile dysfunction
Vardenafil Improves Satisfaction Rates, Depressive Symptomatology, and SelfâConfidence in a Broad Population of Men with Erectile Dysfunction
Keywords: مهارکننده PDE5; Erectile Dysfunction; PDE5 Inhibitor; Vardenafil; Depression; AtâHome Trial;
Sexual Experience of Female Partners of Men with Erectile Dysfunction: The Female Experience of Men's Attitudes to Life Events and Sexuality (FEMALES) Study
Keywords: مهارکننده PDE5; Erectile Dysfunction; PDE5 Inhibitor; Female Sexuality;
Improving the Sexual Quality of Life of Couples Affected by Erectile Dysfunction: A DoubleâBlind, Randomized, PlaceboâControlled Trial of Vardenafil
Keywords: مهارکننده PDE5; Male Erectile Dysfunction; Female Sexual Function; Couple Sexual Function; Vardenafil; PDE5 Inhibitor;